A1 Group, Inc. – Independent Directors and OTCQB Listing Update

SCOTTSDALE, Ariz., June 14, 2023 /PRNewswire/ — A1 Group, Inc. (the “Company” or “AWON”) would like to announce that as named two independent directors as part of its efforts to up list to OTCQB. The OTCQB, also called “The Venture Market,” is the middle tier of the over-the-counter (OTC) market for U.S. stocks. It was created in … Read more

BIOLASE TO PARTICIPATE IN MAXIM GROUP’S 2023 VIRTUAL HEALTHCARE CONFERENCE HOSTED BY M-VEST ON JUNE 20TH

LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that President and Chief Executive Officer, John Beaver and Chief Financial Officer, Jennifer Bright, have been invited to participate in the 2023 Virtual Healthcare Conference, presented by Maxim Group LLC and hosted by M-Vest, on June … Read more

Core Sound Imaging Announces Studycast & EchoSolv™ Integration

Core Sound Imaging and Echo IQ finalize integration agreement for EchoSolv™ and the Studycast® system, through the Studycast Integration Program. This partnership enables Studycast clients to seamlessly integrate AI-powered detection of Aortic Stenosis into their imaging and reporting workflow. RALEIGH, N.C., June 14, 2023 /PRNewswire/ — Core Sound Imaging, Inc., creators of the Studycast system, and … Read more

UK Army & NHSBT Dry Plasma Development Contract Awarded to Velico

Innovation to treat injured soldiers on the battlefield The Army teams up with NHS Blood and Transplant £4.9 million to support clinical trials in the UK BOSTON, June 14, 2023 /PRNewswire/ — An innovative project to rapidly deliver blood and plasma to injured soldiers is set to save lives in warzones.  The UK Ministry of Defence’s … Read more

BioLife Solutions Receives College of American Pathologists CAP-BAP Accreditation for All SciSafe® U.S. Biostorage Facilities

BOTHELL, Wash., June 14, 2023 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies (“CGT”) and broader biopharma markets, today announced that all of its SciSafe-branded biostorage facilities in the USA have been accredited by the College of American Pathologists (CAP). SciSafe … Read more

SilverSneakers to Support 2023 National Senior Games, Cheering on Senior Athletes who Embody Fitness and Healthy Aging

NASHVILLE, Tenn., June 14, 2023 /PRNewswire/ — SilverSneakers® by Tivity Health®, the nation’s leader in senior community fitness and wellness, will sponsor the 2023 National Senior Games, presented by Humana, July 7-18, 2023, in Pittsburgh, PA. SilverSneakers has 18 million eligible members nationwide and supports physical activity for all fitness levels, from beginners to competitive athletes. … Read more

BIOLASE INTEGRATES DIODE LASER TECHNOLOGY WITH PET DENTAL SERVICES

LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ — BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced an arrangement with Pet Dental Services (PDS), the #1 non-anesthetic pet dental provider in the country, to integrate BIOLASE’s diode laser technology. PDS’ vision in the animal health care profession is to gain the trust and … Read more

Improving patient care by making AI tools available to all cardiologists

Removing barriers by making AI tools available for all  RALEIGH, N.C., June 13, 2023 /PRNewswire/ — Core Sound Imaging, Inc., creators of the Studycast® system and other industry-leading cloud-based software solutions for medical imaging and reporting, announced today they will preview the Studycast Integration Program at ASE 2023. The first of its kind, this integration program allows … Read more

Heligenics Unveils A First-Of-Its-Kind Precision Prescription Test For Breast Cancer Therapeutics

LAS VEGAS, June 13, 2023 /PRNewswire/ — Heligenics, a cutting-edge biotech company, announces a first-of-its-kind precision genetic test to select among drugs to treat breast cancer. There are multiple drugs available to treat breast cancer. Most patients become drug resistant, meaning that the cancer cells aren’t responding to the drug that is usually able to … Read more

Biostage to Host Investor Call

HOLLISTON, Mass., June 13, 2023 /PRNewswire/ — Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, including cancer, trauma and birth defects initially in the esophagus and the airway, announced today that it will host an investor call on Tuesday, … Read more